Evidence map›Paper›PMID 29963376›Full record

ReviewJournal of visualized surgery2018

Ten-year experience with the Perceval S sutureless prosthesis: lessons learned and future perspectives.

Vincent Chauvette, Amine Mazine, Denis Bouchard

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of visualized surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Initial experience with the Perceval S sutureless aortic valve.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Vincent ChauvetteDivision of Cardiac Surgery, University of Montreal, Montreal, QC, Canada.
Amine MazineDivision of Cardiac Surgery, University of Toronto, Toronto, ON, Canada.
Denis BouchardDivision of Cardiac Surgery, Montreal Heart Institute, Montreal, QC, Canada.
Montreal Heart Institute · CAUniversité de Montréal · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.

Indexed as

aortic valve replacement (AVR)Perceval S prosthesisSutureless valves

Identifiers

PMID29963376
PMCPMC5994436
OpenAlexW2802609446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.